Search bioRxiv⌕ Search

Biology subjects

Gaudino, R.

Publications and source records attributed to Gaudino, R..

6 recordsLinked to original sources

Integrative Network Analysis Reveals Organizational Principles of the Endocannabinoid System

BackgroundThe endocannabinoid system (ECS) is a complex signaling network that regulates diverse physiological processes, including pain, mood, metabolism, and immune response, through coordinated interactions among receptors, enzymes, and lipid-derived ligands. Despite extensive research on individual ECS components, the systems-level organization and network resilience of the ECS remain underexplored. Here, we present a systems-level analysis of the ECS that integrates protein-protein and protein-chemical interactions into a unified network framework. MethodsWe constructed integrated ECS networks that combine protein-protein and protein-chemical interactions, utilizing data from multiple public databases. Network analyses were performed in Python using NetworkX to assess molecular connectivity and interaction topology. We utilized centrality measures to identify major hubs, employed community detection algorithms to examine the clustering of nodes, and performed targeted perturbations by sequentially removing the top-ranked nodes based on degree and betweenness centrality to assess network robustness. ResultsCentrality analyses identified the primary cannabinoid receptors, cannabinoid receptor 1 (CNR1) and cannabinoid receptor 2 (CNR2), as major hubs with extensive connectivity to endogenous and exogenous ligands. Non-canonical receptors, including transient receptor potential vanilloid 1 (TRPV1) and G-protein coupled receptor 55 (GPR55), also emerged as highly ranked nodes across multiple centrality measures, underscoring their integrative roles within the ECS signaling pathway. Community detection revealed biologically meaningful modules centered around receptor and metabolic clusters, with CNR1, CNR2, anandamide (AEA), 2-arachidonoylglycerol (2-AG), and major phytocannabinoids maintaining key network connectivity. Perturbation analyses demonstrated that removal of top hubs, particularly CNR1, caused pronounced losses in edge connectivity and disrupted signaling pathways among cannabinoids. However, the redistribution of influence toward CNR2 and GPR55 under multi-node removal conditions revealed compensatory plasticity and resilience within the ECS network. ConclusionThis systems-level study highlights the hierarchical and robust architecture of the ECS. The identification of hub nodes, functional communities, and compensatory mechanisms provides insight into how the ECS maintains signaling integrity in the face of perturbation. These findings establish a network-based framework for studying cannabinoid biology and may inform future therapeutic strategies targeting the ECS and its interacting molecular pathways.

systems biology↗

TILLCANN: A TILLING platform in Cannabis sativa for mutation discovery and crop improvement

Cultivation of Cannabis sativa is increasing because of its therapeutic value and recognition as a multi-purpose and sustainable crop. Targeting Induced Local Lesions in Genomes (TILLING) is a versatile reverse genetics approach that unlocks induced variation through mutagenesis to accelerate the development of new cultivars and contribute to the functional validation of genes. Increasingly efficient next-generation sequencing technologies and genomic resources have combined to make TILLING by sequencing (TbyS) an attractive technique that can be applied in cannabis. Here we describe the development of a mutagenesis protocol for C. sativa and the development of the TILLCANN platform composed of 1,633 M2 families. As a demonstration of the functionality of the platform, we used TbyS to perform a high throughput screening of novel mutations in amplicons for genes associated with important agronomic and biochemical traits in a set of 512 M2 families. We confirmed 14 of the identified mutations and calculated an average mutation frequency range of 1/263 to 1/320 kb. We found that heterozygous mutants in the cannabis homologue of Class II TEOSINTE BRANCHED 1/CYCLOIDEA/PCF (TCP4) are linked to alterations in leaf number and morphology. We expect that the novel genetic variability unlocked in the TILLCANN platform for performing forward or reverse genetic screens can significantly boost breeding programs geared toward both medicinal cannabis and industrial hemp. Gene & accession numbersRaw sequencing data generated in this study was deposited at the European Nucleotide Archive with accession numbers xxx and xxx. Genes and accession numbers discussed within this manuscript correspond to the Cannabis sativa cs10 genome assembly deposited in National Center for Biotechnology Information with accession number GCA_900626175.2.

plant biology↗

Evolution, Expansion and Characterization of Cannabinoid Synthase Gene Family in Cannabis Sativa

We are working toward a complete functional and genomic characterization of the cannabinoid synthase family in Cannabis (itself part of the larger Berberine Bridge Enzyme family). This clade, which is unique to Cannabis, includes four main subclades that appear to have arisen by a series of gene duplications. We have functionally characterized three cannabinoid synthases, in addition to the three already characterized, so that now all four subclades contain at least one characterized enzyme. The previously uncharacterized Clade C enzymes have relatively low activity and produce CBCA as their primary product. In addition, we report genomic characterization to better understand the structure and high level of copy number variation in this family. We report a pattern of shared regions immediately upstream of the cannabinoid synthase genes that suggests a specific sequence of breakpoints, and hence gene duplication events. We present a model of gene family expansion to account for the observed data, along with evidence that this expansion occurred under selective pressure. This work adds to our understanding of both the high level of variability in this family and the origin of THCA in type III plants lacking a functional THCAS gene.

genomics↗

Modeling cannabinoids from a large-scale sample of Cannabis sativa chemotypes

The accelerating legalization of Cannabis has opened the industry to using contemporary analytical techniques. The gene regulation and pharmacokinetics of dozens of cannabinoids remain poorly understood. Because retailers in many medical and recreational jurisdictions are required to report chemical concentrations of cannabinoids, commercial laboratories have growing chemotype datasets of diverse Cannabis cultivars. Using a data set of 17,600 cultivars tested by Steep Hill Inc., we apply machine learning techniques to interpolate missing chemotype observations and cluster cultivars together based on similarity. Our results show that cultivars cluster based on their chemotype, and that some imputation methods work better than others at grouping these cultivars based on chemotypic identity. However, due to the missing data for some of the cannabinoids their behavior could not be accurately predicted. These findings have implications for characterizing complex interactions in cannabinoid biosynthesis and improving phenotypical classification of Cannabis cultivars.

plant biology↗

Gene copy number is associated with phytochemistry in Cannabis sativa

Gene copy number variation is known to be important in nearly every species where it has been examined. Alterations in gene copy number may provide a fast way of acquiring diversity, allowing rapid adaptation under strong selective pressures, and may also be a key component of standing genetic variation within species. Cannabis sativa plants produce a distinguishing set of secondary metabolites, the cannabinoids, many having medicinal utility. Two major cannabinoids -- THCA and CBDA -- are products of a three-step biochemical pathway. Using genomic data for 69 Cannabis cultivars from diverse lineages within the species, we found that genes encoding the synthases in this pathway vary in copy number, and that the cannabinoid paralogs may be differentially expressed. We also found that copy number partially explains variation in cannabinoid content levels among Cannabis plants.

genomics↗

Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets

As the most widely used illicit drug, the basis of the fastest growing major industry in the US, and as a source of numerous under-studied psychoactive compounds, understanding the psychological and physiological effects of Cannabis is essential. The National Institute on Drug Abuse (NIDA) is designated as the sole legal producer of Cannabis for use in US research studies. We sought to compare the chemical profiles of Cannabis varieties that are available to consumers in states that have state-legalized use versus what is available to researchers interested in studying the plant and its effects. Our results demonstrate that the federally produced Cannabis has significantly less variety and lower concentrations of cannabinoids. Current research, which has focused on material that is far less diverse and less potent than that used by the public, limits our understanding of the plants chemical, biological, psychological, medical, and pharmacological properties. Investigation is urgently needed on the diverse forms of Cannabis used by the public in state-legal markets.

plant biology↗